Previous | Home | EndoTODAY | List | Next
[Esophageal cancer with adventitia invasion]
Adventitia invasionÀ» º¸ÀÎ ½Äµµ¾Ï »çÁøÀ» ¸ð¾Ò½À´Ï´Ù.
Hollow organÀÎ ½Äµµ, À§, ´ëÀåÀÇ ¿©·¯ ÁúȯµéÀº ³»½Ã°æ °Ë»ç µµÁß¿¡ °ø±â¸¦ ¾ó¸¶³ª ³Ö´Â°¡¿¡ µû¶ó¼ ¸Å¿ì ´Ù¸¥ ¸ð¾çÀ¸·Î º¸ÀÏ ¼ö ÀÖ½À´Ï´Ù. ÇϺνĵµ¿¡ ±Ë¾çÀ» µ¿¹ÝÇÑ ½Äµµ¾ÏÀ¸·Î ÀÇ·ÚµÈ ºÐÀε¥ ÁÂÃø »çÁøÀº °ø±â¸¦ Á¶±Ý¸¸ ³ÖÀº »óÅÂÀÌ°í ¿ìÃø »çÁøÀº °ø±â¸¦ Á» ´õ ¸¹ÀÌ ³ÖÀº »óÅÂÀÔ´Ï´Ù. ½Äµµ°¡ ÃæºÐÈ÷ ÆìÁöÁö ¾ÊÀº »óÅ¿¡¼ ±Ë¾çÀÌ °¡·ÁÁ® º¸ÀÌÁö ¾Ê¾Ò´ø ¿¹ÀÔ´Ï´Ù. ³»½Ã°æÀº ÃæºÐÈ÷ ½Ã°£À» °¡Áö°í °ø±â¸¦ ÀûÀýÈ÷ ³Ö¾ú´Ù »©¾ú´Ù¸¦ ¹Ýº¹ÇÏ´Â °Ë»çÀÓÀ» ´Ù½Ã Çѹø ¾Ë ¼ö ÀÖ¾ú½À´Ï´Ù. ºü¸¥ ³»½Ã°æº¸´Ù´Â ¹Ù¸¥ ³»½Ã°æ. ¿ì¸®ÀÇ mottoÀÔ´Ï´Ù.
1) extension to perimuscular adventitia
2) squamous carcinoma in situ in the background
3) LN 1/36
LN 3/30
LN 5/29
LN 0/59
1) tumor size: 4x2 cm
2) extension to perimuscular adventitia
3) endolymphatic tumor emboli (-)
4) perineural invasion (+)
5) LN 3/62
1) tumor size: 2x1.5 cm
2) extension to perimuscular adventitia
3) extension to stomach
4) endolymphatic tumor emboli (+)
5) perineural invasion (-)
6) LN 1/36
Å©°Ô
À§½ÄµµÁ¢ÇպΠÁ¾¾çÀ¸·Î ½Äµµº¸´Ù´Â À§ÂÊ¿¡ Ä¡¿ìħ. ³»½Ã°æ¸¸À¸·Î´Â À§¾ÏÀÎÁö ½Äµµ¾ÏÀÎÁö ±¸ºÐÀÌ ¾î·Á¿üÀ¸³ª squamous cell carcinoma·Î ³ª¿ÔÀ½. LN 0/56
À§ Áõ·Ê¿Í ºñ½ÁÇÏ°Ô À§½ÄµµÁ¢ÇÕºÎÀÇ Á¾¾çÀ¸·Î ½Äµµº¸´Ù´Â À§ÂÊ¿¡ Ä¡¿ìħ. ³»½Ã°æ¸¸À¸·Î´Â À§¾ÏÀÇ °¡´É¼ºÀÌ Å©´Ù°í º¸¾ÒÀ¸³ª squamous cell carcinoma·Î ³ª¿ÔÀ½. LN 5/60
³»½Ã°æ Áø´Ü: Advanced esophageal cancer, 3 cm, type 3
Esophagus and upper stomach, Ivor Lewis operation : Invasive squamous cell carcinoma, moderately differentiated, middle thoracic esophagus :
1) invasive carcinoma size: 3.5x2.5 cm
2) extension to periesophageal soft tissue (adventitia)
3) endolymphatic tumor emboli: present
4) perineural invasion: not identified
5) resection margins: free from carcinoma, but very close to circumferential resection margin. safety margin: proximal, 4.5 cm ; distal, 8.5 cm ; circumferential (adventitial) margin(deep), 50 §
6) metastasis to 1 out of 29 regional lymph nodes without extracapsular extension, (size of the largest metastasis: 0.4 cm) (1/29 : "7(Subcarinal)", 1/10; "Gastric lymph node 1", 0/2; "Gastric lymph node 3", 0/10; "Gastric lymph node 4", 0; "Lt Recurrent Laryngeal Nerve lymph node", 0/4; "Rt Recurrent Laryngeal Nerve lymph node", 0/3)
7) treatment effect: no prior treatment
[Home]